Robert Landry
Förmögenhet: 781 724 $ per 2026-05-31
Förmögenhet: 781 724 $ per 2026-05-31
Robert E.
Landry is currently Director at Zymeworks, Inc. since 2025, Director at GanD, Inc., Independent Director at Cytokinetics, Inc. since 2025, Chief Financial Officer at Checkmate Pharmaceuticals, Inc. since 2022, and Chief Financial Officer at Decibel Therapeutics, Inc. since 2023.
Former positions include Director-Pharmaceutical Marketing & Sales at Wyeth Australia Pty Ltd. from 2006 to 2007, Treasurer & Principal Corporate Officer at Wyeth LLC from 2007 to 2009, Treasurer & Senior Vice President at Pfizer Inc. from 2012 to 2013, Chief Financial Officer at Wyeth New Zealand from 2004 to 2006, and Chief Financial Officer & Executive VP-Finance at Regeneron Pharmaceuticals, Inc. from 2019 to 2024.
Education includes an undergraduate degree from the University of Notre Dame, conferred in 1986.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-05-27 | 10 184 ( 0,01 % ) | 781 724 $ | 2026-05-31 | |
ZYMEWORKS INC. -.--% | 2026-01-12 | 0 ( -.--% ) | - $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| CHECKMATE PHARMACEUTICALS, INC. | Finansdirektör/CFO | 2022-05-31 |
| DECIBEL THERAPEUTICS, INC. | Finansdirektör/CFO | 2023-09-22 |
| CYTOKINETICS, INCORPORATED | Direktör/Styrelseledamot | 2025-02-10 |
| ZYMEWORKS INC. | Direktör/Styrelseledamot | 2025-08-11 |
GanD, Inc.
GanD, Inc. Medical/Nursing ServicesHealth Services GanD, Inc. is a company based in Miami Beach, FL. George L. Sing has been the CEO of the company since 2016. | Direktör/Styrelseledamot | - |
| Företag | Position | Slut |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Finansdirektör/CFO | 2024-02-05 |
| PFIZER INC. | Företagsledare/Principal | 2012-10-01 |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Treasurer | 2009-10-01 |
Wyeth Australia Pty Ltd. | Finansdirektör/CFO | 2006-01-01 |
| ░░░░░ ░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 11 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Health Technology |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Cytokinetics, Inc.
Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
University of Notre Dame
University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wyeth Australia Pty Ltd. | |
Wyeth New Zealand | |
Checkmate Pharmaceuticals, Inc.
Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
Decibel Therapeutics, Inc.
Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders | Health Technology |
GanD, Inc.
GanD, Inc. Medical/Nursing ServicesHealth Services GanD, Inc. is a company based in Miami Beach, FL. George L. Sing has been the CEO of the company since 2016. | Health Services |
Zymeworks, Inc.
Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån